Sigma-1 receptors and animal studies centered on pain and analgesia-Reference-Cited by-同舟云学术

Sigma-1 receptors and animal studies centered on pain and analgesia

Published:2015-06-03 Issue:8 Volume:10 Page:885-900
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Davis Mellar P¹

Affiliation:

1. Case Western Reserve University, Taussig Cancer Institute, Cleveland Clinic Lerner School of Medicine, Palliative Medicine and Supportive Oncology Services, Division of Solid Tumor, The Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1517/17460441.2015.1051961

Reference198 articles.

1. The sigma-1 receptor chaperone as an inter-organelle signaling modulator

2. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival

3. Sigma binding states in the brain; An emerging concept for multiple sites and their relevance for psychiatric disorders

4. A proposal for the classification of sigma binding sites

5. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy;Palliative Care and Social Practice;2024-01

2. KM-408, a novel phenoxyalkyl derivative as a potential anticonvulsant and analgesic compound for the treatment of neuropathic pain;Pharmacological Reports;2022-11-19

3. Sigma Antagonists for Treatment of Neuropathic Pain Syndromes in Cancer Patients: A Narrative Review;Journal of Cancer Research Updates;2022-10-27

4. Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development;Frontiers in Pharmacology;2022-06-16

5. Pharmacokinetics and brain σ1 receptor occupancy of MR309, a selective σ1 receptor antagonist;British Journal of Clinical Pharmacology;2022-02-03